What This Means for Women in Midlife If you're considering a GLP-1 medication for weight management, the question isn't just "which medication?" it's "what else is going on hormonally?" For women in perimenopause or postmenopause, addressing estrogen deficiency may: Enhance the weight loss response to GLP-1 medications [1] Improve the metabolic benefits including better insulin sensitivity and reduced visceral fat [7, 8] Address symptoms like sleep disruption, hot flashes, and mood changes that can undermine weight loss efforts [10] Support long-term cardiovascular health during a period of accelerated risk [9] This is why a comprehensive approach one that evaluates both your metabolic health and your hormonal status matters so much more than choosing a single medication in isolation
It might have only contributed to her poor skin tone
Of note is that the observed median time to onset of the psychiatric AEs in our analysis of the FAERS data aligned with common gastrointestinal AEs such as nausea and vomiting, which were the most frequently reported within the first 30 days of GLP-1 RA treatment ( In this extensive pharmacovigilance study, we observed a significant association between GLP-1 RAs and eight distinct categories of psychiatric AEs, namely, nervousness, stress, eating disorder, fear of injection, sleep disorder due to general medical conditioninsomnia type, binge eating, fear of eating, and self-induced vomiting
A Texas man purchased what he believed was Ozempic in Nuevo Progreso, Mexico, only to discover it was likely insulin
